Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab effects on basophil proteome in chronic idiopathic urticaria
NCT01701583Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Apr 2013
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in chronic idiopathic urticaria (CIU), sponsored by University of Colorado Denver. Started Apr 2013; status: completed.
02
Drugs
omalizumab
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT01701583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701583.